Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: fred hayes who wrote (9162)	1/9/2006 3:35:34 PM
From: rkrw	Read Replies (4) of 10280

somx needs a partner before you worry about them. Their challenge will be in finding someone willing to spend what it takes even though 10mg is available as a generic albeit off label. On the plus side it's not likely to be scheduled and efficacy seems fine. Hard to say who would be a likely partner. I guess I'm a little more cautious about the whole space esp with ambien going generic. if the market doesn't grow 2-3X I just don't know how every brand is going to make money. Check back in a few years :-) One x-factor for nbix may well be ex-US sales. pfe has a huge presence in Japan.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next